Abbott Laboratories (BMV:ABT)

Abbott Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	43,109	41,950	40,109	43,653	43,075	34,608
Revenue Growth (YoY)	5.85%	4.59%	-8.12%	1.34%	24.46%	8.48%
Cost of Revenue	18,831	18,644	17,919	19,083	18,080	15,003
Gross Profit	24,278	23,306	22,190	24,570	24,995	19,605
Selling, General & Admin	11,329	11,109	10,385	10,703	11,006	9,591
Research & Development	2,862	2,823	2,619	2,741	2,738	2,420
Operating Expenses	15,966	15,810	14,970	15,457	15,791	14,143
Operating Income	8,312	7,496	7,220	9,113	9,204	5,462
Interest Expense	-530	-559	-637	-558	-533	-546
Interest & Investment Income	335	344	385	183	43	46
Currency Exchange Gain (Loss)	39	27	-41	-2	-1	8
Other Non Operating Income (Expenses)	-168	-166	-22	-85	7	13
EBT Excluding Unusual Items	7,988	7,142	6,905	8,651	8,720	4,983
Merger & Restructuring Charges	-233	-129	-144	-234	-509	-
Gain (Loss) on Sale of Investments	-	-	-39	-	-	-115
Gain (Loss) on Sale of Assets	143	-	-	-	-	-
Asset Writedown	-	-	-100	-111	-	-
Legal Settlements	-	-	-	-	-	100
Other Unusual Items	-	-	42	-	-	-
Pretax Income	7,898	7,013	6,664	8,306	8,211	4,968
Income Tax Expense	-6,081	-6,389	941	1,373	1,140	497
Earnings From Continuing Operations	13,979	13,402	5,723	6,933	7,071	4,471
Earnings From Discontinued Operations	-	-	-	-	-	24
Net Income	13,979	13,402	5,723	6,933	7,071	4,495
Preferred Dividends & Other Adjustments	51	51	22	28	29	22
Net Income to Common	13,928	13,351	5,701	6,905	7,042	4,473
Net Income Growth	151.56%	134.18%	-17.45%	-1.95%	57.31%	21.92%
Shares Outstanding (Basic)	1,740	1,740	1,740	1,753	1,775	1,773
Shares Outstanding (Diluted)	1,747	1,748	1,749	1,764	1,789	1,786
Shares Change (YoY)	-0.08%	-0.06%	-0.85%	-1.40%	0.17%	0.28%
EPS (Basic)	8.01	7.67	3.28	3.94	3.97	2.52
EPS (Diluted)	7.97	7.64	3.26	3.91	3.94	2.50
EPS Growth	151.50%	134.36%	-16.62%	-0.76%	57.38%	21.53%
Free Cash Flow	6,775	6,351	5,059	7,804	8,648	5,724
Free Cash Flow Per Share	3.88	3.63	2.89	4.42	4.83	3.21
Dividend Per Share	2.320	2.240	2.080	1.920	1.820	1.530
Dividend Growth	7.41%	7.69%	8.33%	5.50%	18.95%	15.91%
Gross Margin	56.32%	55.56%	55.32%	56.28%	58.03%	56.65%
Operating Margin	19.28%	17.87%	18.00%	20.88%	21.37%	15.78%
Profit Margin	32.31%	31.83%	14.21%	15.82%	16.35%	12.93%
Free Cash Flow Margin	15.72%	15.14%	12.61%	17.88%	20.08%	16.54%
EBITDA	11,453	10,714	10,463	12,380	12,742	8,789
EBITDA Margin	26.57%	25.54%	26.09%	28.36%	29.58%	25.40%
D&A For EBITDA	3,141	3,218	3,243	3,267	3,538	3,327
EBIT	8,312	7,496	7,220	9,113	9,204	5,462
EBIT Margin	19.28%	17.87%	18.00%	20.88%	21.37%	15.78%
Effective Tax Rate	-	-	14.12%	16.53%	13.88%	10.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.